Castle Hook Partners LP Catalent, Inc. Transaction History

Castle Hook Partners LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$56.16 - $60.96 $23.7 Million - $25.7 Million	-422,018 Reduced 50.76%	409,419 $24.8 Million
Q1 2024 May 13, 2024	SELL	$42.56 - $59.82 $8.31 Million - $11.7 Million	-195,365 Reduced 19.03%	831,437 $46.9 Million
Q4 2023 Feb 13, 2024	SELL	$32.18 - $46.57 $32 Million - $46.4 Million	-995,446 Reduced 49.22%	1,026,802 $46.1 Million
Q3 2023 Nov 13, 2023	BUY	$44.2 - $50.2 $12.9 Million - $14.7 Million	292,838 Added 16.93%	2,022,248 $92.1 Million
Q2 2023 Aug 11, 2023	BUY	$31.86 - $67.26 $55.1 Million - $116 Million	1,729,410 New	1,729,410 $75 Million

16.8M

10.7K

53.4K

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Castle Hook Partners LP, based on Form 13F filings with the SEC.

Stay updated on Castle Hook Partners LP with notifications on news.